Skip to main content
BrainCited

Phosphatidylserine için Age-Related Cognitive Decline

B

The FDA has granted a qualified health claim stating phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly. Research suggests modest improvements in memory, learning, and mood in older adults.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dphosphatidylserine\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

The FDA has granted a qualified health claim stating phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly. Research suggests modest improvements in memory, learning, and mood in older adults.

Key Study Findings

Other
Cerebral FURIN deficiency impairs astrocytic lipophagy through ITGAV maturation.
Dose: None vs: None Outcome: astrocytic lipophagy and cognitive function Etki: None None

Popülasyon: cerebral FURIN-deficient mice

Other 4 weeks
Neuroprotective Effect of the Combined Extract of Mentha piperita and Cornus officinalis Against Neuronal Cell …
Dose: 50, 100, or 200 mg/kg/day vs: phosphatidylserine 50 mg/kg/day (positive control) Outcome: cognitive performance in scopolamine-induced memory impairment Etki: None None

Popülasyon: male Sprague-Dawley rats with scopolamine-induced memory impairment

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None vs: None Outcome: Age-dependent brain lipid changes Etki: None None

Popülasyon: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD Etki: None None

Popülasyon: Alzheimer's disease patients

Other
Functional food lycopene mitigates obesity-related cognitive decline via lipid metabolism regulation and neuroprotection via taurine …
Dose: 50 mg/kg lycopene in mice vs: HFD control mice Outcome: Cognitive function (Y-maze, MWM, novel object recognition) Etki: None None

Popülasyon: HFD-induced obese male C57BL/6 mice

Other
Inhibition of miR-4763-3p expression activates the PI3K/mTOR/Bcl2 autophagy signaling pathway to ameliorate cognitive decline.
Dose: None vs: None Outcome: Cognitive function Etki: None None

Popülasyon: Mouse model

Key Statistics

16

Çalışmalar

1100

Katılımcılar

Positive

B

Derece

Referenced Papers

The Senior care … 2021 2 atıf
Nutrition (Burbank, Los … 2015 149 atıf
Current treatment options … 2011 6 atıf
Sports medicine (Auckland, … 2006 42 atıf
Nutritional neuroscience 2002 46 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
100 mg/day
cognitivesupport:
100-300 mg/day

Üst sınır: Well-tolerated up to 600 mg/day

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Negative --
50, 100, or 200 mg/kg/day 4 weeks Positive --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
50 mg/kg lycopene in mice -- Positive --
None -- Positive --
1 μg/mL -- Positive --
None 72 weeks Positive --

En iyi alım zamanı: With meals for better absorption

Safety & Side Effects

Bildirilen Yan Etkiler

  • Mild gastrointestinal discomfort
  • Insomnia at high doses
  • Rare allergic reactions (soy-derived forms)

Bilinen Etkileşimler

  • Anticholinergic medications (may reduce PS effectiveness)
  • Blood thinners (theoretical interaction)
  • Cholinesterase inhibitors (additive cholinergic effects)

Tolere edilebilir üst alım: Well-tolerated up to 600 mg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Phosphatidylserine help with Age-Related Cognitive Decline?
Based on 16 studies with 1,100 participants, there is moderate evidence from clinical studies that Phosphatidylserine may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Phosphatidylserine should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 100 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Phosphatidylserine?
Reported side effects may include Mild gastrointestinal discomfort, Insomnia at high doses, Rare allergic reactions (soy-derived forms). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Phosphatidylserine and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 16 peer-reviewed studies with 1,100 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.